SARS-CoV-2 : Receptor and Co-receptor Tropism Probability

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..

The recent pandemic which arose from China, is caused by a pathogenic virus named "severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2)". Its rapid global expansion has inflicted an extreme public health concern. The attachment of receptor-binding domains (RBD) of the spike proteins (S) to the host cell's membrane, with or without the help of other cellular components such as proteases and especially co-receptors, is required for the first stage of its pathogenesis. In addition to humans, angiotensin-converting enzyme 2 (ACE2) is found on a wide range of vertebrate host's cellular surface. SARS-CoV-2 has a broad spectrum of tropism; thus, it can infect a vast range of tissues, organs, and hosts; even though the surface amino acids of the spike protein conflict in the receptor-binding region. Due to the heterogeneous ACE2 distribution and the presence of different domains on the SARS-CoV-2 spike protein for binding, the virus entry into diverse host cell types may depend on the host cells' receptor presentation with or without co-receptors. This review investigates multiple current types of receptor and co-receptor tropisms, with other molecular factors alongside their respective mechanisms, which facilitate the binding and entry of SARS-CoV-2 into the cells, extending the severity of the coronavirus disease 2019 (COVID-19). Understanding the pathogenesis of COVID-19 from this perspective can effectively help prevent this disease and provide more potent treatment strategies, particularly in vulnerable people with various cellular-level susceptibilities.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:79

Enthalten in:

Current microbiology - 79(2022), 5 vom: 16. März, Seite 133

Sprache:

Englisch

Beteiligte Personen:

Eslami, Narges [VerfasserIn]
Aghbash, Parisa Shiri [VerfasserIn]
Shamekh, Ali [VerfasserIn]
Entezari-Maleki, Taher [VerfasserIn]
Nahand, Javid Sadri [VerfasserIn]
Sales, Abolfazl Jafari [VerfasserIn]
Baghi, Hossein Bannazadeh [VerfasserIn]

Links:

Volltext

Themen:

EC 3.4.15.1
Journal Article
Peptidyl-Dipeptidase A
Receptors, Virus
Review
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2

Anmerkungen:

Date Completed 17.03.2022

Date Revised 16.07.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1007/s00284-022-02807-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM338235426